Two Sigma Securities’s Genprex GNPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-20
Closed -$4.91K 1636
2025
Q2
$4.91K Sell
20
-18
-47% -$5.5K ﹤0.01% 1360
2025
Q1
$10.3K Buy
38
+21
+124% +$11.7K ﹤0.01% 1228
2024
Q4
$16.2K Sell
17
-4
-19% -$5.24K ﹤0.01% 1353
2024
Q3
$8.33K Buy
+21
New +$25.9K ﹤0.01% 2624
2024
Q1
Hold
0
-$4.8K 3196
2023
Q4
Hold
0
2884
2023
Q3
Hold
0
2751
2023
Q2
Sell
-2
Closed -$70.3K 2993
2023
Q1
$70.3K Buy
+2
New +$113K ﹤0.01% 2240
2022
Q4
Hold
0
-$20K 2833
2022
Q3
Hold
0
2297
2022
Q1
Sell
-1
Closed -$42K 2251
2021
Q4
$42K Buy
+1
New +$83.4K ﹤0.01% 1300
2019
Q3
Hold
0
-$14K 2193
2019
Q2
Hold
0
1973

Other funds holding GNPX

Two Sigma Securities's GNPX Position: Q3 2025 in Review

Two Sigma Securities sold out of Genprex (GNPX) in Q3 2025, closing a stake of 20 shares — an estimated $4.91K sold.

Two Sigma Securities first reported a position in GNPX in Q4 2021 and held it in 6 quarters. The position peaked at $70.3K in Q1 2023. 13 funds tracked by Wall St. Rank hold GNPX as of Q3 2025.

  • Two Sigma Securities reported no remaining Genprex position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Securities sold 20 Genprex shares in Q3 2025, an estimated $4.91K.
  • Two Sigma Securities first reported a position in Genprex in Q4 2021 and held it in 6 quarters.
  • Two Sigma Securities's Genprex position peaked at $70.3K in Q1 2023.
  • 13 funds tracked by Wall St. Rank held Genprex as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.